Silexion Therapeutics Corp (SLXN): Cash & Equivalents
$5.99M
As of 2025-12-31
$2.23M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.99M | +404.7% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $1.19M | -74.2% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $4.59M | n/a | 2025-03-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | 2025-12-31 | $5.99M | +404.7% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $5.02M | -55.6% |
| Exozymes Inc. (EXOZ) | 2025-12-31 | $3.04M | -68.7% |
| Calidi Biotherapeutics, Inc. (CLDI) | 2024-12-31 | $9.60M | n/a |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $2.98M | +75.5% |
| Greenland Mines Ltd (GRML) | 2025-12-31 | $7.18M | n/m |
| Eloxx Pharmaceuticals, Inc. (ELOX) | 2025-12-31 | $4.79M | n/m |
| Dyadic International Inc (DYAI) | 2025-12-31 | $4.62M | -29.0% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $1.66M | -15.4% |
Compare SLXN, VIVS, EXOZ, CLDI side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗